Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ping Qiu

Showing results (491-500 of 512) with videos related to

Pageof 52
Sort By:
Nutrition (Burbank, Los Angeles County, Calif.)|December 28, 2022
Effect of early initiation of enteral nutrition on short-term clinical outcomes of very premature infants: A national multicenter cohort study in ChinaLiang Gao, Wei Shen, Fan Wu, et al.
Frontiers in Pediatrics|October 10, 2022
Analysis of "true extrauterine growth retardation" and related factors in very preterm infants-A multicenter prospective study in ChinaWei Shen, Fan Wu, Jian Mao, et al.
International Journal of Cancer|May 4, 2023
KMT2D links TGF-β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticityShuang Lu, Hong Sun Kim, Yubo Cao, et al.
Scientific Reports|June 5, 2024
Real-time predictive model of extrauterine growth retardation in preterm infants with gestational age less than 32 weeksLiang Gao, Wei Shen, Fan Wu, et al.
European Urology|September 2, 2022
Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A StudyEvan Y Yu, Josep M Piulats, Gwenaelle Gravis, et al.
JMIR Public Health and Surveillance|September 2, 2024
Occupational Exposure to Silica Dust and Silicosis Risk in Chinese Noncoal Mines: Qualitative and Quantitative Risk AssessmentKai Liu, Xin Sun, Wei-Jiang Hu, et al.
BMC Pediatrics|March 8, 2024
The role of nutrition in analysis of risk factors and short-term outcomes for late-onset necrotizing enterocolitis among very preterm infants: a nationwide, multicenter study in ChinaKun-Yao Hong, Yao Zhu, Fan Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2019
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 StudyEmmanuel S Antonarakis, Josep M Piulats, Marine Gross-Goupil, et al.
Antiviral Therapy|February 15, 2013
Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trialRobert A Ogert, John A Howe, John M Vierling, et al.
Prostate Cancer and Prostatic Diseases|August 12, 2024
Pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer progressing on enzalutamide: cohorts 4 and 5 of the phase 2 KEYNOTE-199 studyJulie N Graff, Christopher J Hoimes, Winald R Gerritsen, et al.
Pageof 52

Showing results (491-500 of 512) with videos related to

Sort By:
Pageof 52
Nutrition (Burbank, Los Angeles County, Calif.)|December 28, 2022
Effect of early initiation of enteral nutrition on short-term clinical outcomes of very premature infants: A national multicenter cohort study in ChinaLiang Gao, Wei Shen, Fan Wu, et al.
Frontiers in Pediatrics|October 10, 2022
Analysis of "true extrauterine growth retardation" and related factors in very preterm infants-A multicenter prospective study in ChinaWei Shen, Fan Wu, Jian Mao, et al.
International Journal of Cancer|May 4, 2023
KMT2D links TGF-β signaling to noncanonical activin pathway and regulates pancreatic cancer cell plasticityShuang Lu, Hong Sun Kim, Yubo Cao, et al.
Scientific Reports|June 5, 2024
Real-time predictive model of extrauterine growth retardation in preterm infants with gestational age less than 32 weeksLiang Gao, Wei Shen, Fan Wu, et al.
European Urology|September 2, 2022
Pembrolizumab plus Olaparib in Patients with Metastatic Castration-resistant Prostate Cancer: Long-term Results from the Phase 1b/2 KEYNOTE-365 Cohort A StudyEvan Y Yu, Josep M Piulats, Gwenaelle Gravis, et al.
JMIR Public Health and Surveillance|September 2, 2024
Occupational Exposure to Silica Dust and Silicosis Risk in Chinese Noncoal Mines: Qualitative and Quantitative Risk AssessmentKai Liu, Xin Sun, Wei-Jiang Hu, et al.
BMC Pediatrics|March 8, 2024
The role of nutrition in analysis of risk factors and short-term outcomes for late-onset necrotizing enterocolitis among very preterm infants: a nationwide, multicenter study in ChinaKun-Yao Hong, Yao Zhu, Fan Wu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 28, 2019
Pembrolizumab for Treatment-Refractory Metastatic Castration-Resistant Prostate Cancer: Multicohort, Open-Label Phase II KEYNOTE-199 StudyEmmanuel S Antonarakis, Josep M Piulats, Marine Gross-Goupil, et al.
Antiviral Therapy|February 15, 2013
Resistance-associated amino acid variants associated with boceprevir plus pegylated interferon-α2b and ribavirin in patients with chronic hepatitis C in the SPRINT-1 trialRobert A Ogert, John A Howe, John M Vierling, et al.
Prostate Cancer and Prostatic Diseases|August 12, 2024
Pembrolizumab plus enzalutamide for metastatic castration-resistant prostate cancer progressing on enzalutamide: cohorts 4 and 5 of the phase 2 KEYNOTE-199 studyJulie N Graff, Christopher J Hoimes, Winald R Gerritsen, et al.
Pageof 52